Amanda Murphy


William Blair Reiterates Outperform on Illumina, Inc. (ILMN) Despite Weak Outlook for Revenue

In a research report released Wednesday, William Blair analyst Amanda Murphy reiterated an Outperform rating on shares of Illumina, Inc. (NASDAQ:ILMN), following the company’s preliminary …

William Blair Comments On Illumina Following 4Q:14 Results

In a research report sent to investors, William Blair analyst Amanda Murphy maintained an Outperform rating on Illumina (NASDAQ:ILMN), as the company reported fourth-quarter …

William Blair Reiterates Market Perform On Pacific Biosciences Shares

In a research report issued today, William Blair analyst Amanda Murphy reiterated a Market Perform rating on Pacific Biosciences (NASDAQ:PACB). No price target …

William Blair Reiterates Market Perform On Quest Diagnostics Shares

In a research report issued today, William Blair analyst Amanda Murphy reiterated a Market Perform rating on Quest Diagnostics (NYSE:DGX). No price target …

William Blair Maintains Outperform On Myriad Genetics Shares

In a research report issued today, William Blair analyst Amanda Murphy maintained an Outperform rating on Myriad Genetics (NASDAQ:MYGN). No price target was …

William Blair Upgrades Foundation Medicine Shares To Outperform

In a research report issued today, William Blair analyst Amanda Murphy upgraded shares of Foundation Medicine (NASDAQ:FMI) to Outperform rating. No price target was …

William Blair Maintains Market Perform On Pacific Biosciences Ahead Of Third-Quarter Earnings

In a research report issued today, William Blair analyst Amanda Murphy maintained a Market Perform rating on Pacific Biosciences (NASDAQ:PACB), ahead of the company’s …

William Blair Maintains Market Perform On Bio-Reference Laboratories Shares

In a research report issued today, William Blair analyst Amanda Murphy maintained a Market Perform rating on Bio-Reference Laboratories (NASDAQ:BRLI). No price target …

Myriad Genetics: William Blair Provides Key Takeaways Following Travels With Management

In a research report issued today, William Blair analyst Amanda Murphy maintained an Outperform rating on Myriad Genetics (NASDAQ:MYGN), following travels with management, …

William Blair Maintains Outperform On Illumina Following Investor Meeting With Management

In a research report issued today, William Blair analyst Amanda Murphy reiterated an Outperform rating on Illumina (ILMN) with a $200 fair value, following recent investor meeting with CEO Jay Flatley, …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts